ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      98,334.38
      0.13%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. OS Therapies Incorporated (OSTX) Quote

      OS Therapies Incorporated

      OS Therapies Incorporated (OSTX)

      AMEX
      4.26
      0.08
      (1.91%)
      Closed January 05 4:00PM
      Delayed by 15 minutes
      4.48
      0.22
      (5.16%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.26
      Bid
      -
      Ask
      -
      Volume
      54,341
      4.07 Day's Range 4.525
      1.58 52 Week Range 6.48
      Previous Close
      4.18
      Open
      4.19
      Last Trade
      276
      @
      4.26
      Last Trade Time
      Average Volume (3m)
      59,540
      Financial Volume
      $ 234,210
      VWAP
      4.31

      Ask ADVFN Intelligence (AI)

      OSTX Latest News

      More News

      Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

      January 03 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 03 2025
      Edgar (US Regulatory)

      OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference

      CEO Paul Romness available to meet with institutional investors OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates...

      January 02 2025
      Business Wire

      OS Therapies Announces Closing of $6 Million Private Placement

      Funding expected to provide cash runway into 2026 98% of investment in private placement from Pre-IPO and/or IPO investors Data update from OST-HER2 Phase 2b clinical trial in recurrent...

      December 31 2024
      Business Wire

      Form 8-K - Current report

      December 30 2024
      Edgar (US Regulatory)

      OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online

      Digital Marketing Campaign to Highlight Clinical-Stage Cancer Innovation OST-HER2 that activates cellular immunity against HER2+ cancer OS Therapies Joins the B2i Digital Featured Companies...

      December 26 2024
      Business Wire

      OS Therapies Announces Pricing of $6 Million Private Placement

      Funding will provide Company sufficient cash runway into 2026 95% of investment in private placement from Pre-IPO and/or IPO investors Data from OST-HER2 Phase 2b in recurrent, resected...

      December 24 2024
      Business Wire

      Form 8-K - Current report

      November 15 2024
      Edgar (US Regulatory)

      OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

      Topline Data from Phase 2b clinical trial of OST-HER2 in Osteosarcoma expected to be released in December 2024 OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a...

      November 15 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 15 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.14-21.11111111115.45.933.95607614.59232907CS
      42.39127.8074866311.876.481.82481390274.06092694CS
      121.1536.97749196143.116.481.58595403.61931655CS
      260.266.546.481.581248173.73000005CS
      520.266.546.481.581248173.73000005CS
      1560.266.546.481.581248173.73000005CS
      2600.266.546.481.581248173.73000005CS

      OSTX - Frequently Asked Questions (FAQ)

      What is the current OS Therapies share price?
      The current share price of OS Therapies is $ 4.26
      What is the 1 year trading range for OS Therapies share price?
      OS Therapies has traded in the range of $ 1.58 to $ 6.48 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SCPXScorpius Holdings Inc
      $ 0.54
      (56.39%)
      		92.65M
      EVAVDirexion Daily Electric and Autonomous Vehicles Bull 2x Shr
      $ 31.47
      (41.93%)
      		67.51k
      YCBDcbdMD Inc
      $ 0.5664
      (36.81%)
      		10.52M
      SYNXSilynxcom Ltd
      $ 4.98
      (27.12%)
      		768.02k
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 10.21
      (25.43%)
      		48.74M
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 19.24
      (-26.06%)
      		16.46M
      ITPIT Tech Packaging Inc
      $ 0.5227
      (-21.99%)
      		1.83M
      ATCHAtlasClear Holdings Inc
      $ 8.11
      (-19.30%)
      		246.19k
      TSLZT Rex 2X Inverse Tesla Daily Target ETF
      $ 2.35
      (-15.92%)
      		59.36M
      BURUNuburu Inc
      $ 0.6771
      (-15.36%)
      		2.27M
      SCPXScorpius Holdings Inc
      $ 0.54
      (56.39%)
      		92.65M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 29.82
      (7.77%)
      		72.12M
      SPXSDirexion Daily S&P 500 Bear 3X Shares New
      $ 6.10
      (-3.63%)
      		60.33M
      TSLZT Rex 2X Inverse Tesla Daily Target ETF
      $ 2.35
      (-15.92%)
      		59.36M
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 10.21
      (25.43%)
      		48.74M

      OSTX Discussion

      View Posts
      JPetroInc JPetroInc 3 months ago
      looking good Gerald...!

      IMHO, you'll have this trading at $0.00028 in record time



      here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

      so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

      Fortitude Advisors LLC

      https://fortitudeadvisors.com/team/

      "He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

      https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

      I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

      MOO pathetic
      👍️0
      JPetroInc JPetroInc 3 months ago
      uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

      and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

      here we go again folks...!



      buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

      https://ostherapies.com/leadership/

      SMH - can't make this stuff up - sad but true...!

      MOO tool
      👍️0

      Your Recent History

      AMEX
      OSTX
      OS Therapies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads